Adient closed fiscal 2026 with a quarter that split cleanly in two. Revenue was solid, but earnings missed. The seating supplier reported adjusted EPS of $0.52 on revenue of $3.73 billion for the fiscal fourth quarter ended September. EPS fell 14.8% short of the $0.63 consensus and also missed the $0.61 Earnings Whisper number. Revenue beat estimates by 3.9%. Year over year, earnings were flat (0.0%) and revenue grew just 1.1%, so the top-line beat did not turn into growth. The larger issue is the FY27 outlook. It calls for lower revenue, much lower free cash flow, and margin gains that depend heavily on internal execution management has not fully quantified. That is the central tension: FY26 ended with a strong cash result, while FY27 begins with less visibility.

The quality of the quarter deserves scrutiny. On a GAAP basis, Adient posted a net loss of $47 million, or $0.62 per share, compared with adjusted net income of $40 million. Adjusted EBITDA was $229 million, a 6.1% margin. Full-year adjusted EBITDA of $884 million landed essentially on the roughly $885 million guide. Q4 absorbed $22 million of Middle East-related costs, bringing the full-year total to $41 million. That helps explain how a revenue beat still produced an EPS miss. Cash was the clear bright spot. FY26 free cash flow reached $222 million against a guide of about $130 million that management held through Q2 and Q3. Year-end cash of $886 million topped the roughly $800 million expected. Adient also repurchased $100 million of stock during the year, about 6% of shares outstanding at the start of the fiscal year. It paid down $35 million of notes and refinanced its 7% senior secured notes through a $500 million Term Loan B add-on, which management expects to save about $6 million a year in interest.

The call is where the setup changed. FY27 revenue is guided to $14.8 billion to $15.0 billion, down from about $15.2 billion in FY26. That reverses the Q3 message that Adient expected above-market growth in the Americas and China. Management expects global production to fall about 1%, with all key markets lower, and described mix headwinds in the Americas and China as very significant. Unconsolidated China revenue fell about 19% in Q4, worse than the 17% decline in Q3 and the 3% decline in Q1. Europe's growth over market is now a significant unknown, and Asia margins face catch-up compression. Adjusted EBITDA is still guided up to $900 million to $925 million, implying modest margin expansion on lower sales. However, reaching that range implies more than $100 million of business-performance improvement, and management provided less bridge detail than usual. The tone also shifted. In Q3, management spoke of temporary headwinds and positive momentum. This time it called FY27 very challenging.

Cash guidance cools noticeably. FY27 free cash flow is expected to exceed $100 million, less than half the FY26 figure. Part of the drop reflects timing: about $60 million was pulled into FY26, and a $35 million dividend timing benefit will not recur. Adient also expects to return roughly $35 million in IEEPA tariff refunds. Back in Q2, management had discussed FY27 free cash flow potentially exceeding $200 million. That framing is gone, replaced by a two-year cumulative view of about $320 million. That two-year figure does exceed the prior $280 million to $290 million expectation. Further operating risks include:

• fuel surcharges;
• the UAW settlement cost run-rate;
• $30 million to $70 million of Canadian tariff exposure;
• customer downtime in fiscal Q2;
• delayed onshoring launches.

There are offsetting catalysts. Adient raised its buyback authorization by $400 million, to about $1 billion in total commitments, and plans roughly $100 million of repurchases in FY27. It agreed to sell its 50% stake in the FAA seat-frame joint venture in China. It also won a Nissan e-POWER onshoring program of about 40,000 units starting in the second half of FY28, lifting its onshoring backlog above $400 million. Management also adopted an NOL protection plan. Separately, CFO Mark Oswald will hand off to Peter Carlin on November 16, adding a leadership transition just as disclosure is thinning.

The market had already moved toward a cautious stance before the report. Investor sentiment swung from 0.22 to -0.19, a meaningful shift from mildly positive to mildly negative expectations. Shares closed at $16.92 the day before the release. That is 17.5% below the open after the August report and 17.5% beneath the $20.52 200-day moving average. The stock set a 52-week low of $15.91 on October 23 and entered earnings only 6.3% above it, near the bottom of its post-August range. Price and AVWAP trend readings remain negative.

The bottom line is that Adient delivered cash and capital returns but not earnings momentum, and FY27 guidance asks investors to trust margin execution against falling revenue, weak mix, and reduced disclosure. With shares already near 52-week lows, much skepticism may be priced in. Still, bears have legitimate ammunition until the business-performance gains begin showing up in reported results.